OpGen (OPGN) Valuation Rank

View and export this data going back to 2015. Start your Free Trial

What is OpGen Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

OpGen Valuation Rank Related Terms

Thank you for viewing the detailed overview of OpGen's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

OpGen (OPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (NAS:OPGN) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Executives

Yvonne Schlaeppi	director	600 EAST GREENWICH AVENUE, WEST WARWICK X1 02893
Johannes Bacher	officer: Chief Operating Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Albert Weber	officer: Chief Finanical Officer	MARIENBURGER STR. 7, BERLIN 2M 10405
Oliver Schacht	director, officer: Chief Executive Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Evan/ Fa Jones	director, officer: Chief Executive Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
William E. Rhodes	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Curetis N.v. In Liquidation	10 percent owner	MAX-EYTH-STRASSE 42, HOLZGERLINGEN 2M 71088
Mario Crovetto	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Prabhavathi Fernandes	director	114 MILTON AVENUE, CHAPEL HILL NC 27514
Vadim M. Sapiro	officer: Chief Information Officer	C/O OPGEN, INC,, 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
Timothy C Dec	officer: Chief Financial Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Jven Capital, Llc	10 percent owner	P.O. BOX 60207, POTOMAC MD 20859
Tina Susan Nova	director	C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Harry J D'andrea	director	6480 DOBBIN ROAD, COLUMBIA MD 21045